Eritrea

Reimbursed Care Access

Eritrea is a party to the major UN drug control conventions and maintains strict national controls on hallucinogens and empathogens; most classic psychedelics (psilocybin, MDMA, DMT, mescaline, 2C‑X, 5‑MeO‑DMT, ibogaine, ayahuasca) are not authorized for medical use outside research and are effectively illegal for non‑research possession or distribution. Ketamine is used as an essential anesthetic in many low‑resource health systems and is the principal dissociative drug available clinically; esketamine (Spravato) has no public record of national marketing approval in Eritrea and is not reimbursed. There is no public evidence of registered, large‑scale clinical trials of psychedelic‑assisted therapies taking place in Eritrea as of the latest registries and country reporting.